Polyubiquitin based hydrogel and uses thereof
AssigneeViridis Biotech Inc.
InventorMarc Bossé
Life of this patent
Estimating the term…
Loading patent…
AssigneeViridis Biotech Inc.
InventorMarc Bossé
Estimating the term…
The present invention relates to a novel biopolymer consisting of a three-dimensional cross-linked mixture of (a) a cross-linking agent, activated with an activating agent, dissolved in a aqueous solution, and (b) a recombinant protein, namely polyubiquitin. The novel biopolymer is based on the cross-linking of ubiquitin (monomeric and/or polymeric) with a cross-linking agent, preferably bifunctionalized polyethylene oxides or a polyethylene glycol of various molecular masses (MW 2000 to 35 000 kDa), dissolved in aqueous solution in adequate proportions. The novel biopolymer offers a wide range of formulations since the number of ubiquitin units and cross-linking agent can vary both in length and ratio. The novel hydrogel is also biodegradable by a specific protease and is resistant to a wide range of other proteases.
A biopolymer comprising a mixture of ubiquitin and at least one cross-linking agent.
A process for preparing a ubiquitin biopolymer comprising the steps of:
A biopolymer consisting essentially of ubiquitin, acceptable solvent of ubiquitin and at least one cross-linking agent.
Dependencies are inferred from the claim text.